Edition:
United Kingdom

Ben Hirschler

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

03 Dec 2018

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

Unilever swallows GSK's Indian Horlicks business for $3.8 billion

03 Dec 2018

LONDON Unilever is to buy GlaxoSmithKline's Horlicks nutrition business for $3.8 billion (2.98 billion pounds), boosting the Anglo-Dutch group's position in India by adding the popular malted drink.

Millions left behind as diabetes drives surge in insulin demand

21 Nov 2018

LONDON A global diabetes epidemic is fuelling record demand for insulin but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded on Wednesday.

Big pharma leaves big gaps: drugmakers urged to do more for poor

20 Nov 2018

LONDON Many of the world's top drugmakers are not doing enough to provide medicines to poor countries, leaving big gaps in access to treatments in crucial disease areas, including cancer, according to a new report on Tuesday.

Boston Scientific builds medical technology with $4.2 billion BTG deal

20 Nov 2018

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

Pfizer loses drug patent fight in UK top court, may face claims

14 Nov 2018

LONDON Pfizer lost the final round in a lengthy patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the company to possible financial claims.

World News